Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
about
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission.Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-up.Immunomodulatory effects of vitamin D: implications for GVHD.Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study.Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia.Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years.
P2860
Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
@en
Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
@nl
type
label
Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
@en
Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
@nl
prefLabel
Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
@en
Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
@nl
P1476
Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
@en
P2093
Jacob M Rowe
P304
P356
10.1016/J.BEHA.2008.07.002
P577
2008-09-01T00:00:00Z